Summary: EU Pharmaceutical Activity: Challenges Arising From The Pharmaceutical Strategy And Beyond

EUHealthGov started 2023 with its seventh quarterly seminar on 25th January – a roundtable on EU pharmaceutical activity which encompassed challenges from the much-awaited revisions to the EU pharmaceutical strategy and beyond. We were delighted to be joined by a range of experts to consider different aspects, notably solidarity and vulnerability in access to pharmaceuticals; how the EU regards pharmaceuticals through the lens of competition policy; and global access to medicines through EU action. 

Read the full summary here.